Skip to main content

Contact Christine Chiaverini

From: Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial

Contact corresponding author